← All trials
NCT04582942
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 6, 2020
- Primary completion
- Dec 21, 2020
- Completion date
- Dec 25, 2020
- First posted
- Oct 12, 2020
- Last posted
- Oct 28, 2020
- Enrollment
- 2028
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Wuhan UniversityLead sponsor
- Wuhan UniversityReponsible party - principal investigator
- Wuhan UniversityOverall official - principal investigator
- Huazhong University of Science and TechnologyCollaborator
- Hubei University of Chinese MedicineCollaborator
- Wuhan Central HospitalCollaborator
- Huazhong University of Science and TechnologyCollaborator
- Wuhan Puren HospitalCollaborator
- Wuhan Red Cross HospitalCollaborator
- People's Liberation Army of ChinaCollaborator
- Wuhan UniversityCollaborator
- Wuhan University of Science and TechnologyCollaborator
- People's Liberation Army of ChinaCollaborator
- The Central Hospital of WuhanCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.